LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisitions Ambrx has been recently acquired by Johnson & Johnson for $2 billion, indicating a potential partnership opportunity for complementary products or technologies.

Expansion into China China Universal Asset Management invested $104,000 in Ambrx, showing a growing interest in the company's biopharmaceutical offerings and signaling a potential market entry point in China.

Growing Revenue With a revenue range of $10-50 million and a funding amount of $75 million, Ambrx showcases financial stability, making them a strong potential client for partnerships or collaborations.

Focused Portfolio Ambrx is advancing a focused portfolio of clinical and preclinical programs in cancer indications, presenting an opportunity for collaboration with companies specializing in oncology treatments or research.

Technology Stack Utilizing tech tools like Google Analytics and Microsoft Dynamics 365 indicates Ambrx's commitment to innovation, making them an attractive prospect for tech partnerships or solutions providers.

Similar companies to Ambrx

Ambrx Tech Stack

Ambrx uses 8 technology products and services including Google Analytics, Microsoft Word, Microsoft Dynamics 365, and more. Explore Ambrx's tech stack below.

  • Google Analytics
    Analytics
  • Microsoft Word
    Editors
  • Microsoft Dynamics 365
    Enterprise Resource Planning
  • Google Font API
    Font Scripts
  • ADP
    Human Resource Management System
  • ADP HRMS
    Human Resource Management System
  • BugHerd
    Issue Trackers
  • Coupa
    Travel And Expense Management

Media & News

Ambrx's Email Address Formats

Ambrx uses at least 1 format(s):
Ambrx Email FormatsExamplePercentage
First.Last@ambrx.comJohn.Doe@ambrx.com
85%
F.Last@ambrx.comJ.Doe@ambrx.com
11%
First@ambrx.comJohn@ambrx.com
2%
FLast@ambrx.comJDoe@ambrx.com
2%

Frequently Asked Questions

Where is Ambrx's headquarters located?

Minus sign iconPlus sign icon
Ambrx's main headquarters is located at 10975 N Torrey Pines Rd San Diego, CA 92037 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Ambrx's phone number?

Minus sign iconPlus sign icon
You can contact Ambrx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ambrx's stock symbol?

Minus sign iconPlus sign icon
Ambrx is a publicly traded company; the company's stock symbol is AMAM.

What is Ambrx's official website and social media links?

Minus sign iconPlus sign icon
Ambrx's official website is ambrx.com and has social profiles on LinkedIn.

How much revenue does Ambrx generate?

Minus sign iconPlus sign icon
As of August 2024, Ambrx's annual revenue reached $35M.

What is Ambrx's SIC code NAICS code?

Minus sign iconPlus sign icon
Ambrx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 424210 - Drugs and Druggists' Sundries Merchant Wholesalers.

How many employees does Ambrx have currently?

Minus sign iconPlus sign icon
As of August 2024, Ambrx has approximately 117 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer And Gm China: S. S. Z.Chief Financial Officer: S. N.Vice President Procurement: M. M.. Explore Ambrx's employee directory with LeadIQ.

What industry does Ambrx belong to?

Minus sign iconPlus sign icon
Ambrx operates in the Biotechnology Research industry.

What technology does Ambrx use?

Minus sign iconPlus sign icon
Ambrx's tech stack includes Google AnalyticsMicrosoft WordMicrosoft Dynamics 365Google Font APIADPADP HRMSBugHerdCoupa.

What is Ambrx's email format?

Minus sign iconPlus sign icon
Ambrx's email format typically follows the pattern of . Find more Ambrx email formats with LeadIQ.

How much funding has Ambrx raised to date?

Minus sign iconPlus sign icon
As of August 2024, Ambrx has raised $75M in funding. The last funding round occurred on May 24, 2023 for $75M.

When was Ambrx founded?

Minus sign iconPlus sign icon
Ambrx was founded in 2003.
Ambrx

Ambrx

Biotechnology ResearchCalifornia, United States51-200 Employees

Ambrx (Nasdaq: AMAM) is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications. Specifically, ARX517, its proprietary antibody-drug conjugates (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. Ambrx spun out of The Scripps Research Institute in 2003 and has several other product candidates involving ADCs and other aspects of Ambrx’s protein engineering technology.

Section iconCompany Overview

Headquarters
10975 N Torrey Pines Rd San Diego, CA 92037 US
Phone number
Website
ambrx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AMAM
NAICS Code
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
Founded
2003
Employees
51-200

Section iconFunding & Financials

  • $75M

    Ambrx has raised a total of $75M of funding over 9 rounds. Their latest funding round was raised on May 24, 2023 in the amount of $75M.

  • $10M$50M

    Ambrx's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Ambrx has raised a total of $75M of funding over 9 rounds. Their latest funding round was raised on May 24, 2023 in the amount of $75M.

  • $10M$50M

    Ambrx's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.